Pathology Doctors in Marietta, OH Accepting Medicare

2 Pathology doctors found. Showing 1 - 2

Fortunato R Macatol, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Medicare Enrolled Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-374-1499    Fax: 740-374-1766

Dr. Matthew J Macatol, M.D. Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 401 Matthew St, Marietta, OH 45750 Phone: 740-374-1490    Fax: 740-374-1766

News Archive

STRAW+10 report provides general road map to reproductive aging

Published simultaneously today in four top-tier journals, a new report provides a framework within which physicians and researchers can systematically and consistently identify the different reproductive stages women go though from adolescence to menopause and beyond. The report, named STRAW+10, will help clinicians predict when a woman will enter menopause and guide the selection of treatment options for menopausal symptoms and other related conditions.

Drinking soft drinks and other beverages through a properly positioned straw can help to minimize the risk of cavities

Americans drink roughly 576 soft drinks every year - about one and a half cans a day for everyone in the United States. Drinking these beverages places the people who may not follow proper oral hygiene techniques at a higher risk for cavities and other oral health problems.

Western Dental & Orthodontics opens new dental clinic in Dinuba

Western Dental & Orthodontics, one of the nation's leaders in accessible, affordable oral healthcare, today announced the opening of a new, state-of-the-art dental clinic in Dinuba, located at 285 West El Monte Way.

Combination therapy disables PI3K/Akt/mTOR pathway and induces apoptosis in carcinoid syndrome

Oncotarget published "Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis" which reported that microscopic imaging, immunocytochemistry, wound healing assay, caspase-cleaved cytokeratin 18 CytoDeath ELISA assay, immunofluorescence labeling assays for apoptosis, hypoxia, Western Blotting, Tunnel assay, measurement of 5-HT secretion by carbon fiber amperometry assay, quantitative methylation-specific PCR, morphologic changes, cell viability, apoptosis activity and the expression levels of phospho-Akt1, Akt1, HIF-1α, PI3K, p21, CAIX, 5-HT, phospho-mTOR, and mTOR in xenografts derived from typical H727 and atypical H720 BC cell lines.

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Metabolic Solutions Development Company, a drug discovery and development company exploiting novel molecular targets to treat metabolic diseases, announced today that it has launched a Phase 2a trial for MSDC-0602, the company's second drug candidate for the treatment of type 2 diabetes.

Read more Medical News

› Verified 6 days ago